memo - Magazine of European Medical Oncology

Are adjuvant therapies beyond all doubt?

Wolfgang Hilbe, Eberhard Gunsilius

CECOG News

Christoph C. Zielinski

Adjuvant therapy in non-small cell lung cancer: Current status and future perspectives

M. Filipits, R. Pirker

Adjuvant chemotherapy in stage IB non-small cell lung cancer: if, when, how?

M. Dediu

(Neo-)Adjuvant treatment of malignant thymoma

G. Pall

Perioperative therapy in gastric cancer

E. Wöll

Adjuvant therapy of stage II colorectal cancer – who will benefit from treatment?

H. Zwierzina

Consensus on the medical treatment of colon cancer

G. Kornek, W. Scheithauer, R. Anghel, G. Bodoky, F. Ciardiello, T. Ciuleanu, R. Glynne-Jones, T. Gruenberger, I. Koza, J. Ocvirk, L. Petruzelka, G. Poston, G. Ramadori, W. Schmiegel, S. Segaert, J. Tabernero, H. Zwierzina, C. Zielinski

Adjuvant chemotherapy in breast cancer

R. Bartsch, G. G. Steger

Primary chemotherapy and maintenance therapy in epithelial ovarian cancer

A. G. Zeimet, D. Reimer, N. Concin, S. Braun, C. Marth

Congress report: 49th Annual Meeting of the American Society of Haematology, Georgia World Congress Center, December 8–11 2007, Atlanta, Georgia

S. Schmidt, M. Steurer

Update on the treatment of hepatocellular carcinoma

M. Peck-Radosavljevic

Announcement